FDA Inspection 1219663 — Zealand Pharma A/S
The FDA completed an inspection of Zealand Pharma A/S on June 14, 2023 in Soborg. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 14, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Soborg (Denmark)
Additional Details
Postmarket Adverse Drug Experience (PADE)